MedPath

2,4-thiazolidinedione

Generic Name
2,4-thiazolidinedione
Drug Type
Small Molecule
Chemical Formula
C3H3NO2S
CAS Number
2295-31-0
Unique Ingredient Identifier
AA68LXK93C

Overview

Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.

Background

Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/20
N/A
Recruiting
2017/08/15
N/A
Completed
2013/01/28
Phase 3
Completed
2011/11/09
Phase 3
Completed
2009/09/11
Phase 3
Completed
2008/05/26
Phase 3
Completed
2006/11/06
Phase 3
Completed
2006/02/02
Phase 1
Completed
2005/09/21
Phase 1
Completed
2002/10/02
Phase 3
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath